RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of OPTN
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

OptiNose Inc. stock price down 0.95% on Tuesday
(Updated on Jul 02, 2024)

Sell candidate since Jun 17, 2024 Loss -12.61% PDF

The OptiNose Inc. stock price fell by -0.95% on the last day (Tuesday, 2nd Jul 2024) from $1.05 to $1.04. During the last trading day the stock fluctuated 2.94% from a day low at $1.02 to a day high of $1.05. The price has fallen in 8 of the last 10 days and is down by -12.61% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -680 thousand shares and in total, 525 thousand shares were bought and sold for approximately $546.02 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.77% during the next 3 months and, with a 90% probability hold a price between $0.774 and $1.24 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

OPTN Signals & Forecast

There are few to no technical positive signals at the moment. The OptiNose Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.04 and $1.13. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 16, 2024, and so far it has fallen -19.38%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for OptiNose Inc. stock

OptiNose Inc. finds support from accumulated volume at $1.03 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0300 between high and low, or 2.94%. For the last week the stock has had daily average volatility of 8.31%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (OPTN) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect OptiNose Inc. to open at $1.04, and during the day (based on 14 day Average True Range), to move between $0.95 and $1.13, which gives a possible trading interval of +/-$0.0856 (+/-8.23%) up or down from last closing price. If OptiNose Inc. takes out the full calculated possible swing range there will be an estimated 16.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.03 (0.96%) than the resistance at $1.07 (2.88%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is OptiNose Inc. stock A Buy?

OptiNose Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.086 Sell Candidate Unchanged

Predicted Opening Price for OptiNose Inc. of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$1.04 ( 0.321%) $1.04

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for OPTN

Fibonacci Support & Resistance Levels

Level Price
R3 1.07 2.56%
R2 1.06 1.46%
R1 1.05 0.781%
Price 1.04
S1 1.03 -1.42%
S2 1.02 -2.10%
S3 1.01 -3.21%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.14 9.62%
R2 1.13 8.65%
R1 1.07 2.88%
Price 1.04
S1 1.03 -0.96%
S2 0.91 -12.98%
S3 0.86 -17.27%

FAQ

What is the symbol for OptiNose Inc. Stock and on which exchange is it traded?
The symbol for OptiNose Inc. is OPTN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell OptiNose Inc. Stock?
OptiNose Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy OptiNose Inc. Stock?
OptiNose Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy OptiNose Inc. Stock.

What's the current price of OptiNose Inc. Stock?
As of the end of day on the Jul 02, 2024, the price of an OptiNose Inc. (OPTN) share was $1.04.

What is the 52-week high and low for OptiNose Inc. Stock?
The 52-week high for OptiNose Inc. Stock is $2.10 and the 52-week low is $0.80.

What is the market capitalization of OptiNose Inc. Stock?
As of the Jul 02, 2024, the market capitalization of OptiNose Inc. is 152.081M.

When is the next earnings date for OptiNose Inc.?
The upcoming earnings date for OptiNose Inc. is Aug 08, 2024.
Click to get the best stock tips daily for free!

About OptiNose Inc.

OptiNose. OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb c... OPTN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT